共 41 条
- [41] Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income countries [J]. LANCET GLOBAL HEALTH, 2022, 10 (07): : E1045 - E1052